In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks with Prof. James Catto (GB) about the THOR-2 cohort 1 study: Results of erdafitinib (ERDA) vs intravesical chemotherapy (chemo) in patients with high-risk non-muscle-invasive bladder cancer (NMIBC) with select fibroblast growth factor receptor alterations (FGFRALT) who received prior b ... Show More
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
56m 23s
Sep 24
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s
Dec 2022
PARP Inhibitors in Advanced Prostate Cancer Care
PARP Inhibitors in Advanced Prostate Cancer Care Podcast
CME Available: https://auau.auanet.org/node/37321
Host: Jay D. Raman, MD, FACS
Guests: Maha Hussain, MD and Ganesh Raj, MD, PhD
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
1. Identi ... Show More
40m 20s
Apr 2025
S6 E9: Interview with Dr Stephen Bradley on CXR rates in GP & lung cancer; orthostatic HYPERtension; overactive bladder tests
Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode, we are joined by Dr Stephen Bradley, lead author of a new paper published in the BJGP looking at rates of CXR use in general practice and how this influences lung cancer stage at diagnosis and ... Show More
28m 55s
Nov 2020
Covid-19 and comorbidities
A recent meta-analysis by Espinosa and colleagues, “Prevalence of Comorbidities in Patients and Mortality Cases Affected by SARS-CoV2”, found that 42% of patients with Covid-19 had comorbidities. Furthermore, 61% of those with Covid-19 admitted to the Intensive Care Unit had como ... Show More
14m 43s